Recent News

• 06.09.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
• 06.09.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
• 06.02.2025 - Mersana Therapeutics Reports Additional Positive Interim Phase 1 Clinical Data for Emi-Le in Oral Presentation at 2025 ASCO Annual Meeting
• 06.02.2025 - Mersana Therapeutics Reports Additional Positive Interim Phase 1 Clinical Data for Emi-Le in Oral Presentation at 2025 ASCO Annual Meeting
• 05.27.2025 - TD Cowen 6th Annual Oncology Innovation Summit
• 05.27.2025 - TD Cowen 6th Annual Oncology Innovation Summit
• 05.20.2025 - Mersana Therapeutics to Present at Upcoming Investor Conferences
• 05.20.2025 - Mersana Therapeutics to Present at Upcoming Investor Conferences
• 05.15.2025 - CORRECTION - Mersana Therapeutics Provides Business Update and Announces First Quarter 2025 Financial Results
• 05.15.2025 - Mersana Q1 2025 Conference Call

Recent Filings

• 05.15.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.15.2025 - 8-K Current report
• 05.15.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.15.2025 - EX-99.1 EX-99.1
• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors